According to agency sources, the trials were found to be successful.
American biotechnology company Moderna announced the positive conclusion of the first phase of clinical trials of the coronavirus vaccine.
“After taking mRNA-1273 vaccine, the number of antibodies of participants in the trials, depending on the dosage of the drug, was either higher or at the same level in the blood of people with COVID-19”, – said in a statement by Moderna.
In the initial stage, the drug proved to be safe, it is tolerated without complications. The company plans that the final stage for finalizing the clinical trial protocol will begin in July. Reuters notes that after the publication of the communiqué, the company’s share price jumped by 25%.